Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists-Reference-Cited by-同舟云学术

Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists

Published:2024-02 Issue:2 Volume:27 Page:108839
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Popović Lukša,Wintgens Jan P.,Wu Yuxin,Brankatschk Ben,Menninger Sascha,Degenhart Carsten,Jensen Niels,Wichert Sven P.,Klebl Bert,Rossner Moritz J.,Wehr Michael C.^ORCID

Funder

China Scholarship Council

Horizon 2020 Marie Skłodowska-Curie Actions

European Commission

Publisher

Elsevier BV

Reference101 articles.

1. ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications;Jin;J. Clin. Med.,2020

2. Cell Signaling by Receptor Tyrosine Kinases;Lemmon;Cell,2010

3. Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases;Mei;Neuron,2014

4. Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries;Tavassoly;Mol. Pharmacol.,2020

5. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors;Klapper;Proc. Natl. Acad. Sci.,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies;Frontiers in Pharmacology;2024-08-21

2. Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay;STAR Protocols;2024-06

3. Emerging paradigms and recent progress in targeting ErbB in cancers;Trends in Pharmacological Sciences;2024-06

4. Exploiting Cell-Based Assays to Accelerate Drug Development for G Protein-Coupled Receptors;International Journal of Molecular Sciences;2024-05-17